As respiratory virus season begins, pediatric experts are preparing for an expected rise in cases of Respiratory Syncytial ...

Respiratory syncytial virus (RSV) is a common respiratory virus which disproportionally affects new-borns and infants.

The Infectious Diseases Society of America updates flu and RSV vaccine guidelines, emphasizing safety for immunocompromised patients during respiratory virus season. The Infectious Diseases Society of ...

RSV is a leading cause of infant hospitalizations in Canada, with older people and those who are immunocompromised also at greater risk ...

The respiratory syncytial virus vaccine is effective in reducing emergency visits, hospitalizations, and severe illness in ...

Nirsevimab continued to provide strong protection against respiratory syncytial virus-associated bronchiolitis in paediatric EDs during the second season of national immunisation in France.

As the United States heads into the colder weather months, cases of respiratory syncytial virus (RSV) have been ticking up across the country. For the week ending Nov. 25, there were 8,863 positive ...

But figuring out that it was actually RSV, and having friends who’d had RSV and serious complications, it was pretty jarring.

An infant immunization for respiratory syncytial virus (RSV) is now available across Canada, but it still has to be paid for ...

Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the ...

Pregnant individuals at 32-36 weeks can receive the maternal RSV vaccine to protect newborns, and infant RSV vaccines are ...